TY - JOUR T1 - Backward and Hopf bifurcation analysis of an SEIRS COVID-19 epidemic model with saturated incidence and saturated treatment response JF - medRxiv DO - 10.1101/2020.08.28.20183723 SP - 2020.08.28.20183723 AU - David A. Oluyori AU - Ángel G. C. Pérez AU - Victor A. Okhuese AU - Muhammad Akram Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/30/2020.08.28.20183723.abstract N2 - In this work, we further the investigation of an SEIRS model to study the dynamics of the Coronavirus Disease 2019 pandemic. We derive the basic reproduction number R0 and study the local stability of the disease-free and endemic states. Since the condition R0 < 1 for our model does not determine if the disease will die out, we consider the backward bifurcation and Hopf bifurcation to understand the dynamics of the disease at the occurrence of a second wave and the kind of treatment measures needed to curtail it. Our results show that the limited availability of medical resources favours the emergence of complex dynamics that complicates the control of the outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was not required since the work used only publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this manuscript were publicly available data retrieved from Johns Hopkins University Repository. https://github.com/CSSEGISandData/COVID-19 ER -